• PANSS and TESS were used to assess the clinic and side effects.

    用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。

    youdao

  • Symptoms were measured with the positive and negative syndrome scale (PANSS).

    采用阳性与阴性症状量表(PANSS)评定精神症状。

    youdao

  • Psychiatric symptoms were assessed by Positive and Negative Syndrome Scale (PANSS).

    并用阳性和阴性症状量表(PANSS)评定患者的精神症状。

    youdao

  • Positive and negative symptoms scale (PANSS) were used to evaluate the severity of the symptoms.

    用阳性与阴性症状量表(PANSS)于治疗前后对症状严重程度进行评定。

    youdao

  • Mental symptoms and the severity of the disease were evaluated with positive and negative syndrome scale(PANSS).

    用阳性和阴性症状量表(PANSS)评定患者的精神症状及严重程度。

    youdao

  • Brief psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS) were used to assess the effects.

    采用简明精神病量表(BPRS)、阳性和阴性症状量表(PANSS)进行评价。

    youdao

  • The efficacy was evaluated by positive and negative symptom scale(PANSS), and the side effects by treatment emergent symptom scale(TESS).

    以阳性和阴性症状量表(PANSS)评定临床疗效,以副反应量表(TESS)评定不良反应。

    youdao

  • Positive and Negative Syndrome Scale (PANSS) was used to assess the efficacy, side effects scale (TESS) was used to assess adverse reactions.

    采用阳性与阴性症状量表(PANSS)评定疗效,副反应量表(TESS)评定不良反应。

    youdao

  • Results:After 8.12 week treatment, the total scores of PANSS and negative symptom scale were significantly different between two groups(P<0.05).

    结果治疗后8、12周,两组PANSS总分、阴性因子分比较差异有统计学意义(P<0.05)。

    youdao

  • Positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) were used to evaluate the efficacy and side effects respectively.

    用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定疗效和不良反应。

    youdao

  • General information and body mass index (BMI) of the patients were recorded, and the clinical symptoms were assessed with the positive and negative symptom scale (PANSS).

    同时观察记录患者的一般资料、体质量指数等,并用阳性及阴性症状量表(PANSS)评定患者的临床症状。

    youdao

  • All the patients were evaluated with the positive and negative symptoms scale (PANSS) and WHO Quality of Life Survey (WHOQOL 100) before treatment and 1 year after discharge.

    于治疗前、出院1年后采用阳性和阴性症状量表(PANSS)及生活质量量表(WHOQOL - 100)进行精神症状和生活质量的评定。

    youdao

  • Results: After 1 week and 4 weeks treatment, the total scores of PANSS, scores of positive symptoms and psychopathology were significantly decreased in sodium valproate group than in controlled group.

    结果:合用组治疗1周后及治疗结束时PANSS量表总分、阳性症状、精神病理症状的评分比单用组明显为低。

    youdao

  • Results: After 1 week and 4 weeks treatment, the total scores of PANSS, scores of positive symptoms and psychopathology were significantly decreased in sodium valproate group than in controlled group.

    结果:合用组治疗1周后及治疗结束时PANSS量表总分、阳性症状、精神病理症状的评分比单用组明显为低。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定